Literature DB >> 17846785

Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.

Lihong Wang1, Tingjiao Liu, Yao Wang, Lei Cao, Mai Nishioka, Rodelio L Aguirre, Ayataka Ishikawa, Li Geng, Norihiko Okada.   

Abstract

Desmocollin 3 (Dsc3) and desmoglein 3 (Dsg3) are both transmembrane glycoproteins that belong to the cadherin family of calcium-dependent cell adhesion molecules. beta-Catenin is a member of the cadherin-catenin complex that mediates homotypic cell-cell adhesion and is also an important molecule in the wnt signaling pathway. In this study, we examined the simultaneous expression level of Dsc3, Dsg3, and beta-catenin in oral squamous cell carcinomas (OSCCs) and normal oral epithelia using immunohistochemistry. There was a significant correlation (p < 0.05) among the following variables in OSCCs: reduced or loss of expression of Dsc3, Dsg3, and beta-catenin compared to normal oral epithelium, reduced or loss of expression of Dsc3 and histological grade (moderately or poorly differentiated), and reduced or loss of expression of beta-catenin and lymph node metastasis. Furthermore, a positive correlation was found between reduced or loss of beta-catenin staining and reduced or loss of Dsc3 staining in lymph node metastatic cancer tissue (r = 0.734, p < 0.05). These results suggest an abnormal expression of Dsc3, Dsg3, and beta-catenin induced in the progression of oral carcinomas and that the Dsc3 expression level might be related to the regulation of beta-catenin in lymph node metastasis and cell proliferation in OSCCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846785     DOI: 10.1007/s00428-007-0485-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  37 in total

1.  Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.

Authors:  G Saldanha; V Ghura; L Potter; A Fletcher
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

2.  Reduced membranous and ectopic cytoplasmic expression of beta -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer.

Authors:  Q Qiao; M Ramadani; S Gansauge; F Gansauge; G Leder; H G Beger
Journal:  Int J Cancer       Date:  2001-05-20       Impact factor: 7.396

3.  Down-regulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis.

Authors:  J Depondt; A H Shabana; S Florescu-Zorila; P Gehanno; N Forest
Journal:  Eur J Oral Sci       Date:  1999-06       Impact factor: 2.612

Review 4.  Desmosomes and disease: an update.

Authors:  M Chidgey
Journal:  Histol Histopathol       Date:  2002-10       Impact factor: 2.303

Review 5.  Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.

Authors:  A I Barth; I S Näthke; W J Nelson
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

6.  Association of the APC tumor suppressor protein with catenins.

Authors:  L K Su; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

7.  Expression of desmosomal proteins in squamous cell carcinomas of the skin.

Authors:  Hjalmar Kurzen; Ivonne Münzing; Wolfgang Hartschuh
Journal:  J Cutan Pathol       Date:  2003-11       Impact factor: 1.587

8.  Biologic and imaging diagnosis of lymph node metastasis in esophageal carcinoma.

Authors:  Shoji Natsugoe; Saburo Nakashima; Masataka Matsumoto; Hironori Sakita; Fuminori Sakamoto; Hiroshi Okumura; Masamichi Baba; Heiji Yoshinaka; Sonshin Takao; Takashi Aikou
Journal:  J Surg Oncol       Date:  2002-09       Impact factor: 3.454

9.  Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.

Authors:  M Shinohara; A Hiraki; T Ikebe; S Nakamura; S Kurahara; K Shirasuna; D R Garrod
Journal:  J Pathol       Date:  1998-04       Impact factor: 7.996

10.  The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties.

Authors:  M Peifer; P D McCrea; K J Green; E Wieschaus; B M Gumbiner
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  28 in total

1.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

2.  Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.

Authors:  Marianthi Kyrodimou; Dimitrios Andreadis; Angeliki Drougou; Elsa P Amanatiadou; Lefteris Angelis; Calypso Barbatis; Apostolos Epivatianos; Ioannis S Vizirianakis
Journal:  Clin Oral Investig       Date:  2013-02-22       Impact factor: 3.573

3.  Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are associated with aggressive clinicopathological features of oral squamous cell carcinoma.

Authors:  Zhao Xin; Akira Yamaguchi; Kei Sakamoto
Journal:  Virchows Arch       Date:  2014-05-22       Impact factor: 4.064

4.  No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.

Authors:  Dominik Riss; Johannes Pammer; Matthaeus C Grasl; Alexandra Kaider; Sven Schneider; Boban M Erovic
Journal:  Wien Klin Wochenschr       Date:  2014-10-10       Impact factor: 1.704

5.  Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations.

Authors:  Matthias Kreppel; Martin Scheer; Uta Drebber; Lutz Ritter; Joachim E Zöller
Journal:  Virchows Arch       Date:  2010-05       Impact factor: 4.064

6.  Loss of Desmocollin 3 in skin tumor development and progression.

Authors:  Jiangli Chen; Charlene O'Shea; James E Fitzpatrick; Maranke I Koster; Peter J Koch
Journal:  Mol Carcinog       Date:  2011-06-16       Impact factor: 4.784

7.  Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines.

Authors:  Keli Kolegraff; Porfirio Nava; Oskar Laur; Charles A Parkos; Asma Nusrat
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

8.  DSG3 as a biomarker for the ultrasensitive detection of occult lymph node metastasis in oral cancer using nanostructured immunoarrays.

Authors:  Vyomesh Patel; Daniel Martin; Ruchika Malhotra; Christina A Marsh; Colleen L Doçi; Timothy D Veenstra; Cherie-Ann O Nathan; Uttam K Sinha; Bhuvanesh Singh; Alfredo A Molinolo; James F Rusling; J Silvio Gutkind
Journal:  Oral Oncol       Date:  2012-09-23       Impact factor: 5.337

9.  Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma.

Authors:  Cheng Zhan; Li Yan; Lin Wang; Yang Sun; Xingxing Wang; Zongwu Lin; Yongxing Zhang; Yu Shi; Wei Jiang; Qun Wang
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.

Authors:  Xiao Yang; Jing Wang; Wen-Ping Li; Zhi-Jun Jin; Xiao-Jun Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.